BlueOcean (BOV)
More on ICO
Token Sale Oct. 15, 2018 - Dec. 21, 2018
TrackICO Rating 3.1 / 5 ICOMarks Rating 5.1 / 10
Whitelist/KYC Whitelist & KYC
Token price Unspecified
Platform Ethereum

BlueOcean Ventures is a Swiss venture capital firm specialized in investing in ventures from the medical field. For the first time, the BlueOcean STO gives investors the possibility of buying a tradable token (BOV Token) in the highly illiquid asset class of Swiss and European Medtech and life science venture capital investments. 5 Existing portfolio companies, This STO will allow investing in more startups in order to reach a portfolio size of 8 to 12.


Launch of BlueOcean Ventures I


Launch of the second fund, BlueOcean Ventures II


BlueOcean Ventures II invests in Ava AG, Rheon Medical SA, and Abionic SA


BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)

MAY 2018

Set up of Special STO Investment Vehicle in Singapore

JULY 2018

BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO


End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II


BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups


BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company


BlueOcean Ventures II is closed, all remaining assets are distributed to the investors